Pharmacokinetics of micafungin in HIV positive patients with confirmed esophageal candidiasis


Esophageal candidiasis (EC) is a common and serious complication in patients infected with the human immunodeficiency virus (HIV). Micafungin has been shown to have dose-related efficacy and to be well tolerated in patients with HIV and EC. This analysis of data from a randomized, double-blind study examined pharmacokinetic parameters of micafungin (dosed… (More)
DOI: 10.1007/s13318-011-0063-8


8 Figures and Tables